Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Small plates, frequent meals
Compared with GLP-1 alone, dual agonism may provide: greater appetite reduction for some patients improved insulin sensitivity additional metabolic benefits Clinical trials demonstrated substantial weight loss in many patients using tirzepatide for obesity management
GLP-3 RT is used in preclinical research on triple-agonist incretin pharmacology, energy expenditure and thermogenesis, hepatic lipid metabolism, body composition partitioning, and glucose homeostasis
The drug labels for Ozempic, Rybelsus, Wegovy, and Mounjaro all acknowledge that these medications could potentially impact fertility or harm a developing fetus
Application(s): SDS-PAGE, Enzyme Activity
